| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/23/2005 | EP1507772A1 Methods of using thiazolidinedithione derivatives |
| 02/23/2005 | EP1507760A1 Cyanoguanidine prodrugs |
| 02/23/2005 | EP1507759A1 Cyanoguanidine produgs |
| 02/23/2005 | EP1507758A2 Indole derivatives and their use as ligands for cb2 receptors |
| 02/23/2005 | EP1507573A1 Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer |
| 02/23/2005 | EP1507562A1 Methods and compositions for radioimmunotherapy of brain and cns tumors |
| 02/23/2005 | EP1507559A1 Delivery of microparticle-conjugated drugs for inhibition of stenosis |
| 02/23/2005 | EP1507558A1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 02/23/2005 | EP1507556A2 Calicheamicin derivative-carrier conjugates |
| 02/23/2005 | EP1507554A1 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 02/23/2005 | EP1507546A2 Methods of using 22417, a novel human aminoprotease family member |
| 02/23/2005 | EP1507545A1 A terpene-based composition of substances, a method for its preparation and a method for its dispersal into the atmosphere |
| 02/23/2005 | EP1507544A1 Active fraction having anti-cancer and anti-metastasis isolated from leaves and stems of ginseng |
| 02/23/2005 | EP1507542A2 Anti-cancer formulation |
| 02/23/2005 | EP1507536A2 Compositions and their uses for alleviating pain |
| 02/23/2005 | EP1507535A1 Pyrimidine-2,4,6-trione metallo-proteinase inhibitors |
| 02/23/2005 | EP1507534A2 Compounds, compositions and methods |
| 02/23/2005 | EP1507530A1 Diaminothiazoles |
| 02/23/2005 | EP1507528A2 Methods for using jnk inhibitors for treating or preventing disease-related wasting |
| 02/23/2005 | EP1507525A1 Non-steroidal anti-androgen therapy |
| 02/23/2005 | EP1507517A1 Microparticles bearing cells and active substances |
| 02/23/2005 | EP1507514A2 Controlled release compositions of estradiol metabolites |
| 02/23/2005 | EP1317421B1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/23/2005 | EP1286986B1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain |
| 02/23/2005 | EP1261606B1 Substituted oxazolidinones and their use in the field of blood coagulation |
| 02/23/2005 | EP1226128B1 New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 02/23/2005 | EP1107962B1 Quinolin-2-one derivatives useful as anticancer agents |
| 02/23/2005 | EP1066304B1 Macrolide lhrh antagonists |
| 02/23/2005 | EP0876337B1 New lh-rh antagonists with improved effectiveness |
| 02/23/2005 | EP0854709B2 Use of boswellic acid and its derivatives for inhibiting normal and increased leucocytic elastase or plasmin activity |
| 02/23/2005 | CN1585822A Polycistronic expression of antibodies |
| 02/23/2005 | CN1585778A Modified anti-TNF alpha antibody |
| 02/23/2005 | CN1585771A Polycyclic guanine derivative phosphodiesterase V inhibitors |
| 02/23/2005 | CN1585769A A2b adenosine receptor antagonists |
| 02/23/2005 | CN1585757A Oligopeptides and compositions containing them as cathepsin S inhibitors |
| 02/23/2005 | CN1585755A Benzamide and heteroarylamide as P2X7 receptor antagonists |
| 02/23/2005 | CN1585754A Quinazoline derivatives as antitumor agents |
| 02/23/2005 | CN1585750A Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 02/23/2005 | CN1585749A Cannabinoid receptor ligands |
| 02/23/2005 | CN1585647A Compositions comprising matrine and dictamnine for treating or preventing cancer and other diseases |
| 02/23/2005 | CN1585640A N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation |
| 02/23/2005 | CN1585638A Linked biaryl compounds |
| 02/23/2005 | CN1585636A Use of endothelin receptor antagonists in the treatment of tumour diseases |
| 02/23/2005 | CN1585627A Microfabricated nanopore device for sustained release of therapeutic agent |
| 02/23/2005 | CN1583803A Polysaccharose MF4 of mussel with enhancing immunity and anti-tumour activity |
| 02/23/2005 | CN1583800A Anti-tumor activating fuling scloerotium glucan sulfate and its preparation and use |
| 02/23/2005 | CN1583794A Targeted anti-tumour fused protein containing adenovirus E40rf4 protein |
| 02/23/2005 | CN1583762A Axial substituted phthalocyanine compound, its preparation and application in optical kinetic treatment |
| 02/23/2005 | CN1583753A Dioxazole pyrimidine nucleotide compounds with function of releasing NO and its use in pharmaceutics |
| 02/23/2005 | CN1583728A Compound extracted from eucalyptus plant and use thereof |
| 02/23/2005 | CN1583145A Chinese herbal medicine for stomach carcinoma |
| 02/23/2005 | CN1583141A Chinese medicine for cancer |
| 02/23/2005 | CN1583135A Suxiaoan for eliminating oophoritic cyst |
| 02/23/2005 | CN1583134A Effervescent tablets of taraxacum mongolicum and their preparation |
| 02/23/2005 | CN1583130A Frozen dry powder injection of houttuynia cordata and its preparation |
| 02/23/2005 | CN1583127A Chinese medicine for tumour and depression and its preparation |
| 02/23/2005 | CN1583083A Natural medicine and its preparation of eliminating tumour internally |
| 02/23/2005 | CN1583077A Prescription of |
| 02/23/2005 | CN1583004A Composition of cupresulflavone and its preparation |
| 02/23/2005 | CN1582997A Chinese medicine for liver, intestinal and stomach cancers |
| 02/23/2005 | CN1582988A Wuzishan Chinese medicines for cancer pains |
| 02/23/2005 | CN1582973A Garlic frozen dry capsules and their preparation |
| 02/23/2005 | CN1582970A Extraction of effective portion of gryllotalpidae for anti-cancers and its preparation |
| 02/23/2005 | CN1582950A Medicinal composition and its preparation and use |
| 02/23/2005 | CN1582949A Enteric soluble preparation of Alun phosphorate and its preparing method |
| 02/23/2005 | CN1582934A Nano micro granules, their preparation and medicinal uses of campotothecin derivative |
| 02/23/2005 | CN1582933A Nano composition of 9-nitrocamptothecin lipoid and its preparation |
| 02/23/2005 | CN1582932A Hydroxycamptothecin liposome and its preparation |
| 02/23/2005 | CN1582918A Prescription of soybean isoflavone tablets |
| 02/23/2005 | CN1190491C PRV-gene and use thereof |
| 02/23/2005 | CN1190440C Triazolo-epothilones |
| 02/23/2005 | CN1190425C Six kinds of isoquinoline alkaloid |
| 02/23/2005 | CN1190424C Quinoline-containing Alpha-ketoamide cysteine and serine protease inhibitors |
| 02/23/2005 | CN1190423C Heteroycle derivatives and drugs |
| 02/23/2005 | CN1190420C Non-peptide neomatal vascularization inhibitor |
| 02/23/2005 | CN1190418C Process for preparing distamycin derivatives |
| 02/23/2005 | CN1190233C Anti-neoplasm medicine and its preparation method |
| 02/23/2005 | CN1190192C Capsule agent with grape-seed extracts as raw material |
| 02/22/2005 | US6858739 Indole and benzimidazole 15-lipoxygenase inhibitors |
| 02/22/2005 | US6858724 Used as anti-tumor agents and/or anti-HIV agents having immunostimulate activities; inversion of OR2 to OR1 in glucopyranose derivtives (R1= H or acetyl, R2= a leaving group such as tosylate, trifluoromesylate or methanesulfonate |
| 02/22/2005 | US6858714 Cyclic GMP phosphodiesterase |
| 02/22/2005 | US6858651 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 02/22/2005 | US6858644 Use as anti-tumor agents; examples of solvents are N-methyl-2-pyrrolidone and acetonitrile |
| 02/22/2005 | US6858642 For use in pharmaceutical, skin-protective and cosmetic formulations |
| 02/22/2005 | US6858641 Substituted indolinones |
| 02/22/2005 | US6858638 Substituted indazoles, compositions containing them, method of production and use |
| 02/22/2005 | US6858633 Substituted 2-arylbenzazole compounds and their use as antitumour agents |
| 02/22/2005 | US6858628 Substituted cyclic amine metalloprotease inhibitors |
| 02/22/2005 | US6858626 Cyclic hydroxamic acid as metalloproteinase inhibitors |
| 02/22/2005 | US6858621 Mbreast and prostate anticancer agents; viricides; alopecia |
| 02/22/2005 | US6858620 For therapy of male erectile dysfunction; female arousal disorder |
| 02/22/2005 | US6858608 Chemical derivatives and their application as antitelomerase agents |
| 02/22/2005 | US6858603 Acetindine derivatives, their preparation and medicaments containing them |
| 02/22/2005 | US6858597 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase |
| 02/22/2005 | US6858420 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/22/2005 | US6858411 Recombinant nucleic acids that encode epothilone polyketide synthase (PKS) are used to express recombinant PKS genes in host cells to produce epothilone derivatives/polyketides; used as cancer drugs, fungicides and immunosuppressants |
| 02/22/2005 | US6858407 Nucleotide sequences coding polypetide for use in the treatment, prevention and diagnosis of gastrointestinal and apoptosis disorders |
| 02/22/2005 | US6858390 Aptamers containing sequences of nucleic acid or nucleic acid analogues bound homologously, or in novel complexes |
| 02/22/2005 | US6858236 Nutriceutical and drug compositions containing a plant extract or concentrate from the genus Lycopersicon (tomato); bone disorders, e.g., Paget's disease, tumor-induced bone disease or particularly osteoporosis; metabolic disorders |
| 02/22/2005 | US6858235 Antioxidant composition and method of preparation thereof |